CN Patent

CN104254533B — 用作激酶抑制剂的噻唑或噻二唑取代的吡啶基化合物

Assigned to Bristol Myers Squibb Co · Expires 2017-09-08 · 9y expired

What this patent protects

本发明涉及具有下式(I)的化合物，或其对映体、非对映体或药学上可接受的盐，其中X为N或C‑R 7 ，用作激酶调节剂，包括IRAK‑4的调节。

USPTO Abstract

本发明涉及具有下式(I)的化合物，或其对映体、非对映体或药学上可接受的盐，其中X为N或C‑R 7 ，用作激酶调节剂，包括IRAK‑4的调节。

Drugs covered by this patent

Patent Metadata

Patent number: CN104254533B
Jurisdiction: CN
Classification: —
Expires: 2017-09-08
Drug substance claim: No
Drug product claim: No
Assignee: Bristol Myers Squibb Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.